Iag Wealth Partners, LLC Gilead Sciences, Inc. Transaction History

Iag Wealth Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$63.15 - $72.88 $2,462 - $2,842	39 New	39 $2,000
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $5,989 - $6,534	81 New	81 $6,000
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $16,110 - $17,381	-238 Reduced 54.84%	196 $14,000
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $126 - $138	2 Added 0.46%	434 $30,000
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $180 - $205	3 Added 0.7%	432 $28,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $113 - $129	2 Added 0.47%	429 $25,000
Q3 2020 Feb 11, 2021	BUY	$62.1 - $78.08 $186 - $234	3 Added 0.71%	427 $27,000
Q2 2020 Feb 11, 2021	BUY	$72.34 - $84.0 $144 - $168	2 Added 0.47%	424 $33,000
Q1 2020 Feb 11, 2021	BUY	$62.63 - $80.22 $125 - $160	2 Added 0.48%	422 $32,000
Q4 2019 Feb 11, 2021	BUY	$61.62 - $67.78 $25,880 - $28,467	420 New	420 $28,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Iag Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Iag Wealth Partners, LLC with notifications on news.